Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
2017 · European Journal of Cancer · 530 citations
https://doi.org/10.1016/j.ejca.2016.12.001
R
Rénata Ursu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
88
Papers
2.7K
Citations
26
h-index
35
i10-index
Rénata Ursu is an academic researcher from Assistance Publique – Hôpitaux de Paris. The author has contributed to research in topics: Glioma Diagnosis and Treatment & CNS Lymphoma Diagnosis and Treatment & CAR-T cell therapy research. The author has an h-index of 26, co-authored 75 publications.
ORCID: 0000-0003-0123-8937Papers by this author
worksIntracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
2010 · Neuro-Oncology · 203 citations
https://doi.org/10.1093/neuonc/nop047
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
2020 · Scientific Reports · 116 citations
https://doi.org/10.1038/s41598-020-76055-9
Evolution of the Karnosky Performance Status throughout life in glioblastoma patients
2015 · Journal of Neuro-Oncology · 48 citations
https://doi.org/10.1007/s11060-015-1749-6
SARS-CoV-2 infection in patients with primary central nervous system lymphoma
2021 · Journal of Neurology · 10 citations
https://doi.org/10.1007/s00415-020-10311-w
Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study
2024 · Annals of Neurology · 8 citations
https://doi.org/10.1002/ana.27132
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat